Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
No abstract is available for this article. Data Availability Statement Data sharing is not applicable to this article as no datasets were generated or analysed during the current study. References 1, , , et al., “Impact of PD-1 Inhibitor Timing Relative to Locoregional Therapy on Outcomes in uHCC Treated With Lenvatinib-Based Triple Therapy,” Liver International 46, no. 10 (2026): e70847, https://doi.org/10.1111/liv.70847.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
